Related Experiment Videos
Effect of p-chloromercuribenzoate on Clostridium perfringens beta toxin
J Sakurai1, Y Fujii, M Nagahama
1Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Japan.
Abstract:
p-Chloromercuribenzoate (PCMB) was shown to bind to Clostridium perfringens beta toxin. Treatment of the toxin with N-ethylmaleimide (NEM), 5,5'-dithio-bis(2-nitro-benzoic acid) (DTNB), o-iodosobenzoate (OIBA) and metal ions such as Cu2+ and Ag+ decreased the lethal activity, but PCMB did not affect the lethal activity. On the other hand, the binding of PCMB to the toxin was inhibited by DTNB and NEM in a dose-dependent manner. Furthermore, the lethal activity of beta toxin pretreated with PCMB was not blocked by treatment with NEM, DTNB, OIBA, Cu2+ and Ag+. However, the PCMB-treated toxin treated with reduced glutathione, dithiothreitol, 2-mercaptoethanol, liver homogenate or serum from mice was inactivated by NEM.
Insights
p-Chloromercuribenzoate binds Clostridium perfringens beta toxin, but doesn't affect its lethal activity. Pre-treatment with PCMB blocks other inhibitors, suggesting a unique interaction site on the toxin.
Area of Science:
- Microbiology
- Biochemistry
Background:
- Clostridium perfringens beta toxin is a potent lethal agent.
- Understanding toxin-inhibition mechanisms is crucial for developing countermeasures.
Purpose of the Study:
- To investigate the interaction of p-Chloromercuribenzoate (PCMB) with Clostridium perfringens beta toxin.
- To elucidate the effect of PCMB on toxin activity and its binding characteristics.
Main Methods:
- Treatment of beta toxin with various chemical agents including PCMB, N-ethylmaleimide (NEM), and 5,5'-dithio-bis(2-nitro-benzoic acid) (DTNB).
- Assessing the lethal activity of treated toxins.
- Investigating the binding inhibition of PCMB by DTNB and NEM.
Main Results:
- PCMB binds to beta toxin but does not decrease its lethal activity.
- DTNB and NEM inhibit PCMB binding in a dose-dependent manner.
- PCMB pre-treatment prevents inactivation of the toxin by NEM, DTNB, OIBA, Cu2+, and Ag+.
Conclusions:
- PCMB interacts with a distinct site on beta toxin compared to other tested agents.
- The PCMB-binding site may be critical for toxin activity, as its occupation prevents inactivation by other compounds.
- Further research into the PCMB-binding site could reveal novel therapeutic targets.